1261392-52-2
Chemical Structure
(±)-Naproxen-13C,d3
Synonym(s): (Rac)-Naproxen-13C,d3
- CAS No.: 1261392-52-2
- Formula:C1313CH11D3O3
- Molecular Weight:234.27
IUPAC Name: 5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione-2-13C-1,3-15N2
InChIKey: CMWTZPSULFXXJA-JVXUGDAPSA-N
SMILES: OC(C(C1=CC2=C(C=C1)C=C(C=C2)O[13C]([2H])([2H])[2H])C)=O
Biological Activity: (±)-Naproxen-13C,d3 ((Rac)-Naproxen-13C,d3) is the 13C, deuterated-labeled (±)-Naproxen (HY-15029). (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(±)-Naproxen-13C,d3 | (±)-Naproxen-13C,d3 ((Rac)-Naproxen-13C,d3) is the 13C, deuterated-labeled (±)-Naproxen (HY-15029). (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen (Standard) | ≥98% | (±)-Naproxen (Standard) ((Rac)-Naproxen (Standard)) is the analytical standard of (±)-Naproxen (HY-15029). This product is intended for research and analytical applications. (±)-Naproxen is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen-d3 | 99.77% | (±)-Naproxen-d3 ((Rac)-Naproxen-d3) is the deuterated-labeled (±)-Naproxen (HY-15029). (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen-d3-1 | (±)-Naproxen-d3-1 ((Rac)-Naproxen D3 (α-methyl-d3)) is the deuterated-labeled (±)-Naproxen (HY-15029). (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen-13C,d3-1 | (±)-Naproxen-13C,d3-1 ((Rac)-Naproxen-13C,d3-1) is the deuterated, 13C-labeled (±)-Naproxen (HY-15029). (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen | 99.79% | (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
